Cancer BiologybioRxivPreprint
Inhibition of LATS Kinases in Ovarian Cancer Activates Cyclin D1/CDK4 and Decreases DYRK1A Activity
F. Sesay, S. Saini, A. Pajimola…·L. Litovchick
This study shows that inhibiting LATS kinases in ovarian cancer cells activates cyclin D1/CDK4 and reduces DYRK1A activity, promoting tumor growth.
DOI 10.1101/2022.12.06.519357